The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model-Reference-Cited by-同舟云学术

The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model

Published:2021-10 Issue: Volume:72 Page:103595
ISSN:2352-3964
Container-title:eBioMedicine
language:en
Short-container-title:eBioMedicine

Author:

Abdelnabi Rana,Foo Caroline S.^ORCID,Kaptein Suzanne J.F.,Zhang Xin,Do Thuc Nguyen Dan^ORCID,Langendries Lana,Vangeel Laura,Breuer Judith,Pang Juanita,Williams Rachel,Vergote Valentijn,Heylen Elisabeth^ORCID,Leyssen Pieter,Dallmeier Kai,Coelmont Lotte^ORCID,Chatterjee Arnab K.,Mols Raf,Augustijns Patrick,De Jonghe Steven,Jochmans Dirk,Weynand Birgit,Neyts Johan

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference23 articles.

1. A Novel Coronavirus from Patients with Pneumonia in China;Zhu;N Engl J Med,2019

2. The trinity of COVID-19: immunity, inflammation and intervention;Tay;Nat Rev Immunol,2020

3. Medical treatment options for COVID-19;Delang;Eur Hear J Acute Cardiovasc Care,2020

4. Favipiravir at high doses has potent antiviral activity in SARS-CoV-2−infected hamsters, whereas hydroxychloroquine lacks activity;Kaptein;Proc Natl Acad Sci U S A,2020

5. Multicenter, open-labeled efficacy study of Avifavir in patients with COVID-19. Conf. Retroviruses Opportunistic Infect;Yakubova;Virtual,2021

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A validated LC-MS/MS method for determination of Molnupiravir and Favipiravir in human plasma; Assessment of the remarkable potential synergistic effect against SARS-CoV-2 Infection: Application to a pharmacokinetic study in healthy Egyptian volunteers;Microchemical Journal;2024-02

2. Favipiravir induces HuNoV viral mutagenesis and infectivity loss with clinical improvement in immunocompromised patients;Clinical Immunology;2024-02

3. Synthesis and Antiviral Activity of Novel β-D-N4-Hydroxycytidine Ester Prodrugs as Potential Compounds for the Treatment of SARS-CoV-2 and Other Human Coronaviruses;Pharmaceuticals;2023-12-26

4. Preparation and Characterization of Fe-Gallic acid MOF for determination of antiviral Molnupiravir as inhibitor for RNA Corona virus replication;Microchemical Journal;2023-11

5. Chemoprophylactic Assessment of Combined Intranasal SARS-CoV-2 Polymerase and Exonuclease Inhibition in Syrian Golden Hamsters;Viruses;2023-10-27